About us
Platform
Pipeline
Overview
Azelaprag (BGE-105)
BGE-100
Resources
Press releases
In the news
Events
Publications
Presentations
Podcast
Careers
Explore
Press releases
BioAge Appoints Former GSK CEO Jean-Pierre Garnier as Chair of Its Board of Directors
August 22, 2024
BioAge Announces First Patient Dosed in the STRIDES Phase 2 Clinical Trial Evaluating Azelaprag as a Novel Treatment for Obesity in Combination with Tirzepatide
July 29, 2024
BioAge Labs Presents Preclinical Data for Apelin Receptor Agonist Azelaprag for Obesity Demonstrating Significant Improvements in Weight Loss and Body Composition When Combined with Incretin Drugs
June 21, 2024
BioAge Labs Announces Inaugural Scientific Advisory Board to Support Advancement of Novel Therapeutics Targeting Metabolic Aging
May 16, 2024
Show more
Home
About us
Platform
Pipeline
Overview
Azelaprag (BGE-105)
BGE-100
Resources
Press releases
In the news
Events
Publications
Presentations
Podcast
Careers